SCHEMBL3924748

SCHEMBL3924748

N#CNS(=O)(=O)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CA2 P00918 12/20 0.43
CA1 P00915 5/20 0.43
CA7 P43166 1/20 0.38
CA13 Q8N1Q1 1/20 0.38
EPHX1 P07099 1/20 0.31
PTPN1 P18031 1/20 0.30
SLC22A12 Q96S37 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18663420 1.00 CA2 (0.43) CA2CA1CA7CA13EPHX1
SCHEMBL424202 0.74 CA2 (0.46) CA2CA1CA7CA13EPHX1
SCHEMBL15116346 0.72 CA1 (0.43) CA2CA1CA7CA13EPHX1
SCHEMBL18161393 0.72
SCHEMBL10465401 0.72 CA1 (0.43) CA2CA1CA7CA13EPHX1
Water SCHEMBL27093600 0.69 CA2 (0.53) CA2CA1CA7CA13EPHX1
SCHEMBL15116350 0.69 CA1 (0.40) CA2CA1EPHX1
Water SCHEMBL30690960 0.67 CA2 (0.50) CA2CA1CA7CA13EPHX1
SCHEMBL6691815 0.67
SCHEMBL4457449 0.65 CA2 (0.56) CA2CA1CA7CA13EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115717051-B Silicone adhesive protective film and optical element comprising same 三星SDI株式会社 2024-07-30 CN disclosed
CN-113728252-B Silicone adhesive protective film and optical element comprising same 三星SDI株式会社 2023-05-16 CN disclosed
CN-115717051-A Silicone adhesive protective film and optical element comprising same 三星SDI株式会社 2023-02-28 CN disclosed
US-20220206190-A1 SILICONE-BASED ADHESIVE PROTECTION FILM AND OPTICAL MEMBER COMPRISING SAME SAMSUNG SDI CO., LTD. (KR) 2022-06-30 US disclosed
EP-2565886-A1 Material for electrolytic solution, ionic material-containing composition and use thereof Nippon Shokubai Co., Ltd. (JP) 2013-03-06 EP disclosed
US-8273263-B2 Ionic compound NICHICON CORPORATION (JP) 2012-09-25 US disclosed
US-8124869-B2 Dye-sensitized type solar cell NIPPON SHOKUBAI CO., LTD. (JP) 2012-02-28 US disclosed
US-7914927-B2 Material for electrolytic solutions and use thereof NIPPON SHOKUBAI CO., LTD. (JP) 2011-03-29 US disclosed
US-20100173195-A1 MATERIAL FOR ELECTROLYTIC SOLUTIONS AND USE THEREOF NIPPON SHOKUBAI CO., LTD. (JP) 2010-07-08 US disclosed
US-7713658-B2 Material for electrolytic solutions and use thereof NIPPON SHOKUBAI CO., LTD. (JP) 2010-05-11 US disclosed
US-7541492-B2 Perfluoroalkanesulfonamide compounds TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2009-06-02 US disclosed
US-20080138704-A1 Material for Electrolytic Solution, Ionic Material-Containing Composition and Use Thereof NIPPON SHOKUBAI CO., LTD. (JP) 2008-06-12 US disclosed
US-20080083626-A1 IONIC COMPOUND NICHICON CORPORATION (JP) 2008-04-10 US disclosed
US-20070093678-A1 Novel perfluoroalkanesulfonamide compounds TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2007-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080138704-A1 Material for Electrolytic Solution, Ionic Material-Containing Composition and Use Thereof ANO1, CLIC1, HCN1 CA2 70/4885CA1 10/4885CA7 28/4885
US-20080083626-A1 IONIC COMPOUND KCNN4, HCN2, CLCN2 CA2 38/4885CA1 40/4885CA7 232/4885
US-20100173195-A1 MATERIAL FOR ELECTROLYTIC SOLUTIONS AND USE THEREOF SCO2, AOC1, GPX1 CA2 225/4885CA1 10/4885CA7 210/4885
US-20070093678-A1 Novel perfluoroalkanesulfonamide compounds AFF2, AFF4, AFF1 CA2 687/4885CA1 2537/4885CA7 676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.